Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
With the buyout, global private equity investor Nordic Capital makes a big bet on healthcare AI. Arcadia said the influx of cash will be used to improve its technology and find new sources for data it can use for quality care initiatives.
The two companies will continue combining components to make patient monitoring systems, under the new terms of the expanded deal that includes a "pledge program" to improve quality.
Current Health—purchased by Best Buy for $400 million in 2021—is set to become an independent company again, with co-founder Christopher McGhee taking over. The electronics retailer appears to be backing away from remote patient monitoring services, shifting its healthcare division's focus to consumer products that improve the lives of seniors.
The U.S. is one of 23 countries that consider workforce AI training and education only a medium priority. Indeed, our homeland has a less detailed plan than 13 other nations.
Citing two sources familiar with the matter, journalists at CBS News said the health system is suspected of violating the Foreign Corrupt Practices Act. No charges have been filed.
When it comes to adopting healthcare AI, large, well-off hospitals are likely to frequently homer while smaller, struggling institutions go down looking. (Baseball analogy in honor of tonight’s Midsummer Classic.)
Morphic's new treatment for inflammatory bowel disease is in Phase II clinical trials and shows promise in improving patient outcomes. Eli Lilly will purchase the company for $57 per share in cash.